Company intelligence / Profile preview

Phosphorex

Hopkinton, Massachusetts, United Statesphosphorex.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Phosphorex does not have its own clinical results as it operates as a CDMO supporting client projects through all phases of formulation development. It has expertise in encapsulation technologies that enable improved bioavailability, controlled release, and targeted drug/nucleic acid delivery.

Therapeutic areas: OncologyImmunology
Modalities: Lipid Nanoparticles (LNPs)Polymeric Nanoparticles (PNPs)Polymeric Microspheres (PMPs)Nucleic acid delivery systemsParticle-based drug delivery
Industry: Contract Manufacturing Organization

Partnerships

NOF Corporation

Beyond the preview

Go deeper on Phosphorex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphorex.